Lazard Asset Management
PRTK

Lazard Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Lazard Asset Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-31,266
Closed -$559K – 1139
2017
Q4 		$559K Buy
+31,266
New +$559K ﹤0.01% 762